Go to main content

Diabetes Medications

Zepbound

Zepbound (Tirzepatide) FDA-Approved for Chronic Weight Management

metformin

Does Metformin Benefit People With Type 1 Diabetes?

A woman with possible heart issue

Could Jardiance Help People Who Have Experienced a Heart Attack?

New data from a large clinical trial of adults who had experienced a recent heart attack showed that the SGLT-2 inhibitor Jardiance reduced the risk of hospitalizations for heart failure by 33%. 

Type 1 on a GLP-1 Drug? Watch for Hypoglycemia and DKA

Explore GLP-1 agonists for weight loss in type 1 diabetes with caution. Understand potential risks like hypoglycemia and DKA, while balancing benefits for heart and kidney health.

Switching Away From Levemir: What Are the Options?

Novo Nordisk to discontinue Levemir, impacting patients who rely on its unique dosing flexibility for diabetes management.

How GLP-1s Impact Birth Control

Explore the emerging effects of GLP-1 receptor agonists on glycemic control and weight management, including their potential impact on birth control pill absorption and fertility.